![John Lewicki](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 24 785 $ al 31/08/2026
Dr. John A. Lewicki is a Chief Scientific Officer at Mereo BioPharma Group Plc.
Dr. Lewicki was previously employed as a President, Chief Executive Officer & Director by OncoMed Pharmaceuticals, Inc. and a Principal by Scios, Inc. He received his doctorate degree from the University of California San Diego.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/02/2026 | 464.130 ( 0,06 % ) | 24 785 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Director Técnico/Científico/I+D | 01/07/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Director Ejecutivo | 23/04/2019 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
 Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
